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Public preferences for engagement in Health Technology Assessment
decision-making: protocol of a mixed methods study
Abstract

Background Much attention in recent years has been given to the topic of public engagement in health
technology assessment (HTA) decision-making. HTA organizations spend substantial resources and time on
undertaking public engagement, and numerous studies have examined challenges and barriers to engagement
in the decision-making process however uncertainty remains as to optimal methods to incorporate the views
of the public in HTA decision-making. Little research has been done to ascertain whether current engagement
processes align with public preferences and to what extent their desire for engagement is dependent on the
question being asked by decision-makers or the characteristics of the decision. This study will examine public
preferences for engagement in Australian HTA decision-making using an exploratory mixed methods design.
Methods/Design The aims of this study are to: 1) identify characteristics about HTA decisions that are
important to the public in determining whether public engagement should be undertaken on a particular
topic, 2) determine which decision characteristics influence public preferences for the extent, or type of
public engagement, and 3) describe reasons underpinning these preferences. Focus group participants from
the general community, aged 18-70 years, will be purposively sampled from the Australian population to
ensure a wide range of demographic groups. Each focus group will include a general discussion on public
engagement as well as a ranking exercise using a modified nominal group technique (NGT). The NGT will
inform the design of a discrete choice study to quantitatively assess public preferences for engagement in HTA
decision-making. Discussion The proposed research seeks to investigate under what circumstances and how
the public would like their views and preferences to be considered in health technology assessments. HTA
organizations regularly make decisions about when and how public engagement should occur but without
consideration of the public's preferences on the method and extent of engagement. This information has the
potential to assist decision-makers in tailoring engagement approaches, and may be particularly useful in
decisions with potential for conflict where clarification of public values and preferences could strengthen the
decision-making process.
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Abstract
Background: Much attention in recent years has been given to the topic of public engagement in health technology
assessment (HTA) decision-making. HTA organizations spend substantial resources and time on undertaking
public engagement, and numerous studies have examined challenges and barriers to engagement in the
decision-making process however uncertainty remains as to optimal methods to incorporate the views of the
public in HTA decision-making. Little research has been done to ascertain whether current engagement processes align
with public preferences and to what extent their desire for engagement is dependent on the question being asked by
decision-makers or the characteristics of the decision. This study will examine public preferences for engagement
in Australian HTA decision-making using an exploratory mixed methods design.
Methods/Design: The aims of this study are to: 1) identify characteristics about HTA decisions that are important
to the public in determining whether public engagement should be undertaken on a particular topic, 2) determine
which decision characteristics influence public preferences for the extent, or type of public engagement, and 3)
describe reasons underpinning these preferences. Focus group participants from the general community, aged
18–70 years, will be purposively sampled from the Australian population to ensure a wide range of demographic
groups. Each focus group will include a general discussion on public engagement as well as a ranking exercise
using a modified nominal group technique (NGT). The NGT will inform the design of a discrete choice study to
quantitatively assess public preferences for engagement in HTA decision-making.
Discussion: The proposed research seeks to investigate under what circumstances and how the public would like their
views and preferences to be considered in health technology assessments. HTA organizations regularly make decisions
about when and how public engagement should occur but without consideration of the public’s preferences on the
method and extent of engagement. This information has the potential to assist decision-makers in tailoring engagement
approaches, and may be particularly useful in decisions with potential for conflict where clarification of public values and
preferences could strengthen the decision-making process.
Keywords: Health technology assessment, Discrete choice study, Decision-making, Mixed methods, Public engagement

Background
There is increasing recognition of the role and importance
of public engagement in health technology assessment
(HTA) decision-making. HTA is a multidisciplinary process
that summarises information about the medical, social, economic and ethical issues related to the use of a health technology. It aims to inform the formulation of safe, effective,
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health decisions and policies that are patient-focused and
represent value for money [1]. Public engagement is a
means to achieve these aims, because it increases the
transparency of the process and provides a mechanism
to consider social values related to the technology being
assessed [2–4]. Most organizations involved in HTA conduct some form of consultative or participative public
engagement to inform decision-making [5]. However, HTA
organizations (HTAOs) have traditionally made their own
independent judgments regarding who to engage, the
method of engagement and at what point in the HTA
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continuum to engage. The basis on which these decisions
are made is unclear, as there is a lack of published evidence
as to when public engagement should be undertaken, how
it should be obtained and under what circumstances it is
most effective [6].
Generally public engagement is used as a broad term
to cover a number of different types of dialogue; from
basic information provision to more complex deliberation and collaboration. Many frameworks have been
published to conceptualize the differences between types
of engagement with most conceptualizing a continuum
whereby each successive type represents an increasing
degree of influence, commitment and/or participation
[7, 8]. In HTA, public engagement methods can include
basic information provision, to consultative mechanisms
such as focus groups and consumer representation on
decision making committees [9], to more complex
methods of deliberation including citizens juries and
consensus panels [5].
Public engagement frameworks suggest that the complexity and the impact of a topic (in this case the HTA)
should influence the type of engagement undertaken by
a decision-making organization [10]. The difficulty arises
in defining what is meant by ‘complexity’ and ‘impact’ in
HTA. Some authors have suggested that complexity
relates to the nature of the evidence base: this includes
issues such as the type of the technology under review,
the research question, and/or the quantity and quality of
the evidence available [11].
In contrast, ‘impact’ relates to the inferred effect of a
decision on the broader population [12] and is often
portrayed as relating to the interests of the stakeholders
involved [11]. In HTA these stakeholders include health
professionals, pharmaceutical companies, device manufacturers as well as the public and patient organizations.
The interests of these groups are driven by both the
characteristics of the target population and the disease
(condition) as well as the technology. As such, understanding the effect of a decision involves issues such as
the number of people with the condition, their characteristics (e.g. age, ethnicity), the perceived benefit of the
technology (relative to the severity/burden of the condition), the availability of other treatment options, whether
expert opinion is divided on the effectiveness of the
technology and the cost of the technology [13].
Issues around complexity and impact have been
described in the literature as external decision-making
context factors [12], i.e., those factors that are fixed,
uncontrollable and cannot be manipulated by decisionmakers but to do with the context of the HTA itself.
(such as prevalence of the condition, quality of the evidence). Internal decision-making context factors, on the
other hand, are factors relating to the decision-making
process [12]. Such factors include the time and resources
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available to the HTAO, the organizational cultural of the
HTAO. These factors are rarely made explicit in public
engagement frameworks, but have been noted as being
just as influential in determining when and how members of the public would be engaged [11, 14, 15].
Although a number of studies [16, 17] have been
undertaken in the public engagement and HTA sphere,
most have examined the importance of these factors one
at a time. Additionally many of these studies are from
the perspective of the decision maker and none have
specifically considered the views of the general public. It
may be that in some circumstances the public are happy
not to be involved in decision-making [18, 19]; particularly if the existing systems are transparent and already
capture a diversity of views [20]. Understanding the relative value of such factors (or what we refer to as ‘characteristics of a HTA decision’) depends upon considering
several of them simultaneously and allowing individuals
to weigh and trade-off these factors to clarify which aspects might be relevant under what circumstances [21].
This will enable us to determine for which policy questions the public consider public engagement would be
best undertaken. The next step would be for policy
makers to clarify what they want from the public in
these circumstances [20] including the extent to which
they are willing to cede or not, to the public’s views.
The objectives of this study are to determine if and
how the public would like their views and preferences to
be considered in HTAs and whether this differs depending upon the question posed by decision-makers and/or
the characteristics of the HTA.

Methods/Design
In order to determine the public’s preferences on engagement in HTA, we will undertake a mixed methods
study involving focus groups and a discrete choice experiment (DCE). The approach will involve collecting
both qualitative and quantitative data from focus groups,
followed by an online DCE to quantitatively assess the
public’s preferences for engagement in HTA decisions
and the trade-offs individuals are willing to make between engagement methods depending on the characteristics of the individual HTA decision. Fig. 1 outlines the
sequence for the proposed study. Stage one will focus on
views of the public in respect to public engagement and
HTA decision-making whereas stage two will explore
the link between these views and different engagement
methods. As there is an extensive body literature on
public engagement [22], a series of literature reviews will
be undertaken to inform both stages. These will be used
to outline what is already known on the topic and to
better define the tools and to assist with interpretation
of findings.
Focus groups and nominal group technique
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Fig. 1 Sequence of the public preferences for engagement in Health Technology Assessment decision‐making mixed methods study

Focus group discussions incorporating a modified
nominal group technique will be used, alongside a review of the literature, to establish the attributes for the
DCE. Nominal group techniques (NGT) are a formal
consensus development method based on structured
group discussion [23]. This method supports idea generation and enables exploration and debate of views
within a group; which is particularly useful in situations
where participants are likely to have diverse views on a
subject or where limited existing research evidence is
available [24]. This technique also prevents individual
participants from controlling the discussion, and allows
all participants the opportunity to share their suggestions and opinions [25]. In comparison to traditional
NGT, generation of ideas in this study will be undertaken as part of the focus group rather than as an individual exercise. Such techniques (both focus groups
and modified NGT) have been used successfully in conjunction with DCEs [24, 26, 27].
Discrete choice experiments
DCEs are quantitative surveys in which respondents
are asked to choose between hypothetical alternatives
defined by a set of attributes with varying levels. The
method is underpinned by the theory that goods and
services, including health care services or policies, can
be described in terms of separate attributes [28, 29]. The
levels of attributes are varied systematically in a series of
questions and respondents choose the option that they
prefer for each question. People choose their most preferred option, interpreted as the option from which they
derive the highest ‘value’ or ‘utility’ [30]. From these
choices, a mathematical function is estimated in a random utility framework which estimates the probability

with which options are chosen; subsequently the relative
importance or value of different attributes can be investigated. Other data collected in the survey, including
attitudinal questions and sociodemographic information,
can also be included as explanatory variables. Therefore,
DCEs can explore which attributes are driving public
preferences, the trade-offs between attributes that people
are willing to accept, and how changes in attributes can
lead to changes in preferences.
Attribute identification and selection is an important
part of DCE design. The process of attribute identification
determines the options that the individual sees and ultimately shapes the policy conclusions that can be drawn
from the DCE [31]. Good practice in DCE design is for
qualitative work to drive the identification and selection of
attributes. This allows researchers to explore and understand concepts that will ultimately guide the design, development and analysis of the DCE [30] and assist in
increasing the validity of the design and the analysis [32].
Therefore, we will use a combination of qualitative and
quantitative methods and the existing HTA public engagement literature, to determine which attributes will be included in our DCE [26]. Such attributes may cover both
issues of ‘complexity’ and ‘impact’ of a topic including severity of the condition, number of people with the condition who could benefit, certainty of the evidence and
availability of alternatives [21, 33]. This literature will also
inform the conduct of our focus groups.
Study design
Stage one: Focus/nominal groups

The focus group discussions will centre on participants’ views on public engagement in Australian HTA
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decision-making. All focus/nominal groups will be
begin with a brief introduction to HTA. Following this
each focus/nominal group discussion will then have
four main phases: discussion around public engagement practices in HTA and the adequacy of these
methods; preliminary questions about the characteristics of a HTA that are important in decision-making, a
group discussion of the characteristics (or factors) affecting decision-making and public engagement, and an
individual ranking exercise involving the factors identified
from the group discussion [34]. Examples of recent HTA
decisions will be used to prompt discussion.
The aims of the focus/nominal group component are to:
1. explore the views of the public in respect to public
engagement in HTA decision-making,
2. identify characteristics (factors) about individual
HTAs (such as seriousness of the problem, number
of people affected, quality of the evidence) that are
important in determining whether public
engagement should be undertaken on a particular
topic,
3. develop a rank ordering of the factors elicited in aim
2 to be used in a DCE on public engagement in
HTA, and
4. describe reasons underpinning their choices and
rankings.
A minimum of six groups with approximately 10 participants per group will be convened. All groups will be
conducted in metropolitan areas of NSW and run for
around 2 hours. Participants will be recruited via a market research company and will be grouped by age to facilitate communication with their peers and because age
is known to be a factor influencing participation preferences in health decision making [35, 36]. Purposive sampling will be undertaken to ensure a balance of numbers
between male and female participants, cultural backgrounds, education and employment history, socioeconomic and parental status [37]. Prior to each group
discussion participants will receive a participant information sheet about the study, and will be asked to sign a
consent form before each focus groups begins. Each participant will receive AU $100 at the end of the focus
group to cover time and travel costs.
Selection of HTA examples (case studies)

Four case studies of recent HTA decisions will be presented
as part of the focus groups:
1) Ipilimumab for advanced stage melanoma
2) injection of Botulinum toxin for chronic migraine
3) magnetic resonance imaging (MRI) for diagnosis of
Crohn’s disease
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4) hypobaric oxygen therapy (HBOT) for chronic skin
ulcers.
The details presented in these case studies will be
based on publically available data from recent Australian
HTA reports reviewed by either the Medical Service
Advisory Committee [38, 39] or Pharmaceutical Benefits
Advisory Committee [40, 41]. It is not intended that
these examples be the focal point of the groups, rather
that they offer concrete examples to prompt discussion.
The four case studies reflect HTAs of potentially varying
‘impact ‘and ‘complexity’ and thus are intended to
prompt different responses from the participants in
regards to public engagement. Additionally, the examples vary in terms of the public engagement processes
actually employed. It is anticipated that this will assist in
elucidating issues around the use of different methods of
public engagement in HTA. For example if the public
considers complex decisions and those of potentially
greater impact warrant public engagement, then it
should follow that the characteristics reflected in the advanced melanoma and chronic migraine case studies will
be raised in the focus group. This is because both these
examples require trade-offs between different social
values (e.g., seriousness of the problem, uncertain benefit, costs). In contrast, the characteristics of the Crohn’s
case study, in terms of both complexity and impact, are
considered to be more straightforward and likely to require fewer trade-offs.
Focus group questions

Focus/nominal group participants will be asked a range
of open- and closed-ended questions, including broad
questions on public engagement and HTA as well as
more specific questions on the case studies. These questions will assist in the generation of a list that can be
used in the modified nominal group exercise. From the
list of decision aspects important in determining if public engagement should be undertaken, participants will
be asked to rank the factors from 1 (most important) to
10 (least important).
Data collection and analysis
Qualitative

Focus group discussions will be audio-recorded and
transcribed. Transcripts will be imported into the computer software package Nvivo 10 which will be used to
facilitate coding and analysis of the qualitative data.
Concepts relating to HTA and public engagement will
be identified inductively from the data. Similar concepts
will be grouped into themes [42]. We will also identify
relationships among themes. The analysis will be performed for all groups collectively; we will also explore
whether any differences exist across sub-groups. The
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preliminary analysis will be discussed among all investigators to ensure that the full breadth and depth of data
are captured in the results.
Quantitative

Individual respondent rankings will be used to calculate
importance scores for each factor (or characteristic)
identified in the focus groups. The highest-ranked factor
for each respondent will be given 10 points, the next
most important given 9, and so on, progressively down
to least important being given 1. Factors not included in
an individual’s top 10 will be given a score of 0. The individual rankings will be summed to derive rank orders
at the group and overall levels; mean and median
weighting importance scores will also be calculated, as
well as the percentage of all respondents who ranked
each factor in their top ten. Other methods of analysis
of the group data such as the frequency and proportion
of participants who included a factor in their ranking list
will also be undertaken [43].
Stage two: Discrete choice experiment (DCE)

The thematic analysis, in conjunction with the strength
and frequency of each factor within a theme, will be
used to determine the key attributes [44]. Once the attributes and levels have been decided based on the qualitative work and the literature, a statistically efficient DCE
design will be generated [45]. It is likely attributes will
include, but not be limited to, factors such as prevalence
of the condition, cost to the taxpayer, size of health gain.
Once an initial design has been created, it will be piloted
in a sample of 50 participants and preliminary models
estimated. Parameter estimates from these will be used
to generate the final efficient design for the main
discrete choice study. In addition to the discrete choice
questions, information on socio-demographic characteristics and exposure to health decision-making processes
of respondents will also be collected.
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representative of the Australian public, recruited using
quota sampling based on age and gender. Respondents
will be recruited by a market research company with an
existing online panel and experience in administering
online choice-based surveys. The final sample size
required will be based upon the characteristics of the
design itself, such as the number of attributes included,
the attribute level range, the number of choice scenarios presented, the number of alternatives in each choice
set and the size and direction of prior parameters obtained from the pilot study. The DCE will also include an
opt-out option as well as scenario that describe the status
quo in relation to public engagement. To ensure that we
are able to explore interactions between attributes and between attributes and socio-demographic factors, along
with unobserved heterogeneity we anticipate a sample size
of at least 1000 respondents.
The results from this survey will inform policy by
highlighting the factors that influence community preferences for engagement with HTA decision making. We
will initially use a mixed multinomial logit (MMNL)
(also known as random parameters logit, RPL) model
using a panel specification for the analysis. A panel specification of the model allows for non-independence of
observations provided by the same respondent; that is it
can account for correlations amongst the multiple
choices made by the same individual. We will also explore
the use of alternative model specifications such as panel
latent class models and generalized multinomial logit
models to estimate preferences for community engagement. We will examine interactions between attributes,
and between attributes and population characteristics
(for example, age, gender, income, education, nonenglish speaking background) before deciding on a final
model specification. Model results will expressed as
parameter estimates (β), the odds of choosing one option instead of another (and 95 % confidence intervals
of the odds ratios) and p-values. Acceptable trade-offs
between attributes will also be calculated.

Aims of the DCE component
Ethical considerations

1. to assess if the public would like their preferences
to be considered in HTA decision-making
2. to determine how the public would like their
views and preferences to be considered in HTA
decision-making
3. to determine quantitatively which factors influence
the public’s preferences in respect to how public
engagement should be undertaken for individual
technology decisions.
Data collection and analysis

The DCE survey will be conducted using a web-based
questionnaire administered to a respondent sample broadly

This study has been approved by the University of Sydney
Ethics Committee (2014/053 and 2014/1022). Confidentiality and anonymity of the data will be strictly maintained.
Digital recording of the focus groups will only take place
after written informed consent is obtained from participants. Participants will not be identifiable in any transcripts,
or in any publications. It will be made clear to all participants that they have the right to withdraw from the
research at any point in time.

Discussion
This study will use qualitative and quantitative methods
to determine the Australian public’s preferences for
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engagement in HTA. It will build upon other studies of
public engagement and social values in HTA, but will
focus on ordinary or lay citizens rather than stakeholder
groups such as patients or decision-makers. Stage one of
the study will generate two separate outputs: a qualitative analysis of issues around public engagement,
prioritization and resource allocation in health technology,
and a ranked list of the characteristics that the public considers the most important in determining whether or not
public engagement should be undertaken in HTA. Stage
two of the study (i.e., the DCE) will allow quantification of
the importance of each attribute (characteristic) in determining how public engagement should be undertaken in
Australian HTA. Our research will produce a uniquely
comprehensive understanding of the preferences of the
public on when and how they would like engagement; this
information can be used by health care agencies and
decision-makers to tailor public engagement methods and
inform future research on public engagement methodology.
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